SEC Accuses Drugmaker of Venomous Deceptions
A Florida-based microcap securities issuer that claimed to make pain relievers with cobra venom is accused by the U.S. Securities and Exchange Commission in a civil complaint filed Friday of misleading...To view the full article, register now.
Already a subscriber? Click here to view full article